OCD cannot be permanently cured in the way you might cure an infection, but it can be treated effectively enough that symptoms become minimal or disappear entirely. Clinicians call this “remission,” defined as no longer meeting the diagnostic criteria for the disorder and having only minimal symptoms. With the right combination of therapy, and sometimes medication, roughly one-third to two-thirds of people who complete treatment reach that point. The practical difference between remission and a cure is that OCD can return, especially if treatment stops, so long-term management matters.
What Remission Actually Looks Like
Clinicians track OCD severity using a standardized scale called the Y-BOCS, which scores symptoms from 0 to 40. Remission generally means scoring 12 or below, which corresponds to a roughly 55% reduction from where most people start treatment. At that level, intrusive thoughts may still appear occasionally, but they no longer drive compulsive behavior or significantly interfere with daily life. Many people in remission describe OCD as background noise rather than a controlling force.
Exposure and Response Prevention Therapy
The most effective treatment for OCD is a specific type of cognitive behavioral therapy called Exposure and Response Prevention, or ERP. The idea is straightforward: you gradually face the situations, thoughts, or images that trigger your obsessions while practicing not performing the compulsive behavior that usually follows. Over time, your brain learns that the anxiety decreases on its own without the ritual.
ERP has decades of evidence behind it. In studies of treatment completers, 60 to 70% are rated “much improved.” One intensive outpatient program that delivered about 22 hours of coached ERP over two weeks found that 90.5% of participants showed at least a partial response, 57% showed a full response, and one-third reached remission by the final assessment. Intensive formats like this, where therapy happens several hours a day over a short period, can compress months of weekly sessions into weeks.
Standard ERP typically involves weekly sessions over 12 to 20 weeks. The early sessions focus on building a hierarchy of feared situations ranked by difficulty, then working through them systematically. Dropout is one of the biggest challenges because the process requires sitting with discomfort. When accounting for people who refuse, drop out, or don’t respond, the long-term success rate is closer to 55%.
Cognitive Therapy as an Alternative
Some people find the direct confrontation of ERP too overwhelming. Cognitive therapy for OCD takes a different angle, targeting the distorted beliefs that maintain the cycle. Instead of jumping straight into exposure, it helps you examine why your brain treats certain thoughts as dangerous and restructure those interpretations. In head-to-head comparisons, cognitive therapy and ERP produce statistically similar outcomes. One study found 67% of cognitive therapy completers reached “recovered” status at post-treatment compared to 59% for ERP, though the difference wasn’t statistically significant. For people who might otherwise drop out of ERP, cognitive approaches can be a viable path to the same destination.
Medication for OCD
OCD responds to a narrower range of medications than depression or general anxiety. The primary options are SSRIs (selective serotonin reuptake inhibitors) and one older tricyclic antidepressant. Five medications carry FDA approval for OCD in adults: fluoxetine, sertraline, paroxetine, fluvoxamine, and clomipramine.
A critical difference from treating depression is dosing. OCD typically requires higher doses, sometimes above what the FDA label lists. Specialists routinely prescribe fluoxetine at 80 mg (occasionally up to 120 mg) and sertraline at up to 400 mg. These higher doses are supported by clinical evidence and professional guidelines. Equally important is patience: a proper trial means staying at the maximum tolerated dose for 12 to 16 weeks before concluding the medication isn’t working. Many people give up too soon.
Medication alone rarely produces remission as reliably as therapy, but the combination of an SSRI with ERP tends to outperform either one alone, particularly in moderate to severe cases.
Why Stopping Treatment Carries Risk
One of the most important things to understand about OCD management is the relapse pattern. A large meta-analysis published in The BMJ found that discontinuing medication roughly tripled the odds of relapse compared to staying on it. Among people switched to a placebo, 36.4% relapsed, versus 16.4% of those who continued their medication. The time to relapse was also significantly shorter after discontinuation.
This doesn’t mean you’ll be on medication forever. Many people successfully taper off after a sustained period of stability, especially if they’ve also completed a full course of ERP. The skills learned in therapy appear to have a more durable effect than medication alone, which is one reason therapists emphasize completing the full course rather than stopping once you feel better.
Brain Stimulation for Severe Cases
When therapy and multiple medication trials fail, a treatment called transcranial magnetic stimulation (TMS) is one option. The FDA cleared a specific TMS device for OCD in 2018 based on a study of 100 patients. Among those who received active stimulation, 38% responded, compared to 11% in the placebo group. The treatment involves repeated sessions where magnetic pulses are delivered to specific brain areas. The most common side effect is headache, and earplugs are required during treatment because the device is loud. TMS is non-invasive and doesn’t require anesthesia.
For the most severe, treatment-resistant cases, deep brain stimulation (DBS) is a surgical option. This involves implanting electrodes in specific brain structures. Studies report response rates between 40% and 67%, with symptom reductions ranging from 30% to 45%. DBS is reserved for people who have exhausted all standard treatments, and it requires careful screening and long-term follow-up with a specialized team.
Mindfulness as a Supporting Practice
Mindfulness-based cognitive therapy has shown promise as an add-on to standard OCD treatment, not as a standalone cure. Research suggests it can reduce obsessive-compulsive symptoms, modify dysfunctional beliefs, and improve quality of life. The core skill it builds, observing thoughts without reacting to them, complements what ERP teaches. Mindfulness practice helps you notice an intrusive thought, label it as just a thought, and let it pass without engaging in a compulsion. It works best layered on top of ERP or medication rather than replacing them.
Putting a Treatment Plan Together
The most effective approach for most people combines ERP (or cognitive therapy) with medication when symptoms are moderate to severe. Starting with therapy alone is reasonable for milder cases. If weekly sessions feel too slow or symptoms are disrupting your ability to function, intensive programs that deliver therapy in concentrated blocks over two to four weeks can accelerate progress significantly.
Expect the process to take months, not weeks. A realistic timeline involves 12 to 16 weeks to find the right medication dose, a similar period for a full course of ERP, and then ongoing maintenance. Some people stay on a lower medication dose long-term as insurance against relapse. Others maintain their gains through periodic “booster” therapy sessions. The goal isn’t perfection. It’s reaching a point where OCD no longer dictates your decisions, and for the majority of people who commit to treatment, that goal is reachable.